市場調查報告書
商品編碼
1309866
2018-2028年ELISA分析儀市場 - 全球行業規模、佔有率、趨勢、競爭、機會及預測F 按類型、按模式、按應用、按最終用戶、按地區和競爭情況進行細分ELISA Analyzers Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, 2018-2028F Segmented By Type, By Mode, By Application, By End user, By Region and Competition |
預計在2024-2028 年的預測期內,ELISA 分析儀市場將以驚人的複合年成長率成長。這主要歸因於對診斷傳染病流行的高效測試需求不斷成長,以及對技術先進的疾病檢測儀器的需求不斷成長等因素。
疾病在人群中的流行率不斷上升,推動了ELISA 分析儀的市場需求。傳染病發病率在全球範圍內不斷上升,引起了全世界人民對健康的極大關注。例如,根據世界衛生組織的數據,2019 年有2.96 億人感染乙型肝炎,每年新增感染者約150 萬人。同樣,根據世衛組織的報告,登革熱病的全球負擔有所增加,觀察到約310 萬例病例,其中超過2.5 萬例被認為是嚴重病例。隨著癌症、肝炎、愛滋病等傳染病發病率的快速成長,對診斷的直接需求也隨之激增,從而在預測期內推動了市場的成長。例如,印度製藥公司Biocon 在2020 年增加了投資,花費了5879 萬美元。
準確、快速地分析生化和免疫參數的維護是分析免疫測試結果的重要要求。分析儀的設計旨在確保檢測的理想性能,如保持靈敏度、降低背景噪音和快速重現性。此外,ELISA 分析儀(如開放式系統自動分析儀)配有預編程測試菜單和簡單指南,有助於節省安裝時間,同時為用戶提供方便。例如,2022 年5 月,高性能生命科學解決方案的領先供應商Molecular Devices, LLC.該公司為酶聯免疫吸附試驗(ELISA)工作流程推出了五種現成的新型工作單元,可提供自動化品質,如增加走行時間和吞吐量,減少大量樣品中的勞動密集型重複工作,因此預計未來幾年市場成長將激增。
酶活性的測量以及可溶性蛋白、細胞因子和其他蛋白體的檢測,都促進了ELISA 分析儀的市場需求。此外,越來越多的過敏病例也導致了對ELISA 等診斷技術的需求。 ELISA 是一種廣泛用於檢測食物過敏的診斷技術。此外,由於間接IgE-ELISA 方法與其他自動化系統相比簡單、成本低,因此經常用於檢測血清樣本中的過敏原特異性IgE。例如,2018 年7 月,Dynex Technologies 宣布與ZEUS Scientific 建立全球合作夥伴關係。 2021 年8 月,Zeus Scientific Inc 獲得FDA 授權,可使用Dynex Agility、Dynex DSX 或Dynex DS2 自動ELISA 系統運行ZEUS ELISA SARS-SoV-2 總抗體檢測系統。隨著COVID-19 期間ELISA 檢測試劑盒銷售量的增加和需求的上升,ELISA 分析儀的市場需求激增,預計在預測期內將促進ELISA 分析儀市場的發展。
ELISA 可用於量化抗體滴度,而抗體滴度可進一步用於疫苗開發過程中的免疫原性評估。因此,一些致力於疫苗開發的公司對ELISA 分析儀的需求不斷增加。例如,根據2022 年7 月舉行的2022 年第二季度業績會議的最新消息,領先的製藥公司賽諾菲公司有10 種候選疫苗正在研發中。
TechSci Research 可根據給定的市場數據,按照公司的具體需求提供客製化服務。報告可提供以下客製化選項:
ELISA Analyzers Market is expected to grow with an impressive CAGR in the forecast period of 2024-2028. This can be attributed to factors such as increasing demand for efficient tests for diagnosing the prevalence of infectious diseases and the growing need for technologically advanced instruments for disease detection, etc.
Enzyme-Linked Immunosorbent Assay (ELISA) is a laboratory test that is utilized for the detection of antibodies in the blood. The ELISA is based on the principle of antibody and antigen interaction and, thereby, is utilized in disease diagnosis. Analyzers are automated instruments that perform distinct steps of the assays and provide accurate and reproducible outcomes.
Moreover, the growing incidences of HIV, hepatitis, cancer, etc., and the rising involvement of ELISA analyzers in research and development involved in immunology and drug development are propelling the market demand for ELISA analyzers and thus supporting the market growth and are expected to propel it in the forecast period.
The growing prevalence of a disease among the population is propelling the market demand for ELISA analyzers. Rising infectious disease prevalence is growing worldwide, causing a huge health concern among people around the world. With this rapid increase in the account for infectious diseases such as cancer, hepatitis, HIV, etc., there is a surge observed in the direct demand for diagnosis and, thus, is adding to the market growth by propelling the market in the forecast period. For instance, Indian-based pharmaceutical company Biocon increased investment and spent USD 58.79 million in the year 2020.
The accuracy and quick analysis of the biochemical and immunological parameters maintenance is a significant requirement for the analysis of immunological test results. Analyzers are designed in such a way as to ensure the ideal performance of the assays, such as maintaining sensitivity, lesser background noise, and quick reproducibility. Also, the ELISA analyzers, such as open system automated analyzers, are fitted with pre-programmed test menus and simple guides that aid in saving installation along with providing the user convenience. For instance, In May 2022, Molecular Devices, LLC., a leading provider of high-performance life science solutions, launched its automated work cells for ELISA workflows. The company introduced its five readymade new work cells for Enzyme-linked immunosorbent assay (ELISA) workflows, which provide automation qualities such as increased walkaway time and throughput, reducing the labor-intensive, repetitive work in large samples, and thereby is expected to surge the market growth in the coming years.
The measurement of enzyme activity, along with the detection of soluble proteins, cytokines, and other protein bodies, is fueling the ELISA analyzers' market demand. Additionally, the growing case of allergies has led to demand for diagnostic techniques such as ELISA. ELISA is a widely used diagnostic technique in the detection of food allergies. Furthermore, the indirect IgE-ELISA method is frequently used to detect allergen-specific IgE in serum samples due to its simplicity and low cost compared with other automated systems. For instance, In July 2018, Dynex Technologies announced its global Partnership with ZEUS Scientific. In August 2021, Zeus Scientific Inc obtained FDA authorization to use the Dynex Agility, Dynex DSX, or Dynex DS2 Automated ELISA Systems to run the ZEUS ELISA SARS-SoV-2 total antibody test system. The surge in market demand for ELISA analyzers is experienced with the increased sales and rising demand for ELISA test kits during the COVID-19 duration and is anticipated to bolster the ELISA analyzer market in the forecast period.
ELISA is utilized to quantify antibody titers which are further utilized for the assessment of immunogenicity during vaccine development. Hence, several companies leading to their vaccine development have an increased demand for ELISA analyzers. For instance, a leading pharmaceutical company, Sanofi Incorporation, has 10 vaccine candidates in its pipeline, according to the latest updates at the Q2 2022 results meeting, which was held in July 2022.
ELISA Analyzers Market is segmented based on the type, mode, application, end-user, and region. Based on the type, the market is further segmented into optical filter ELISA analyzers and optical grating ELISA analyzers. Based on the mode, the market is segmented into automated ELISA analyzers and semi-automated analyzers. Based on application, the market is further fragmented into immunology, vaccine development, drug monitoring, and others. Depending on the End-user, the market is segmented into biotechnology companies, pharmaceutical companies, contract research organizations, and diagnostic laboratories. Based on the region, the Market is further segmented into North America, Europe, Asia-Pacific, South America, and MEA.
Thermo Fisher Scientific, Abcam, Bio-Rad Laboratories, Merck KGaA, F. Hoffmann-La Roche Ltd, Danaher Corporation, BioTech, Agilent Technologies, QIAGEN, and PerkinElmer Inc.., etc.., are some of the major players operating in the Global ELISA Analyzers Market.
In this report, Global ELISA Analyzers Market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in ELISA Analyzers Market.
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: